Oxaprozin

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

奥沙普秦是一种非麻醉性非甾体类抗炎药 (NSAID)，用于缓解与骨关节炎和类风湿性关节炎相关的炎症、肿胀、僵硬和关节疼痛。

Oxaprozin is a non-narcotic, non-steroidal anti-inflammatory drug (NSAID) used to relieve the inflammation, swelling, stiffness, and joint pain associated with osteoarthritis and rheumatoid arthritis.(In Vitro):Oxaprozin induces apoptosis in a dose-dependent manner. Oxaprozin increases caspase-3 activity in the activated but not in the resting condition. NF-κB activation is inhibited by Oxaprozin (50 μM). Oxaprozin inhibits activation of the IKK system induced by the reagent IκBα.Oxaprozin (100 μM) induces the strongest proapoptotic effect and significantly increases CD40L-treated monocyte apoptosis. Oxaprozin treatment inhibits CD40L-induced Akt and NF-κB (p65) phosphorylation.

Oxaprozin induces apoptosis in a dose-dependent manner. Oxaprozin increases caspase-3 activity in the activated but not in the resting condition. NF-κB activation is inhibited by Oxaprozin (50 μM). Oxaprozin inhibits activation of the IKK system induced by the reagent IκBα.Oxaprozin (100 μM) induces the strongest proapoptotic effect and significantly increases CD40L-treated monocyte apoptosis. Oxaprozin treatment inhibits CD40L-induced Akt and NF-κB (p65) phosphorylation.

——

Daypro | NSC 310839 | Wy 21743

Chromatin/Epigenetic

COX

COX

Other Indications

——

21256-18-8

293.32

C18H15NO3

>98% (HPLC)

Ethanol: 27 mg/mL (92.04 mM); DMSO: 59 mg/mL (201.14 mM)

CC1COC2=C3N1C=C(C(O)=O)C(C3=CC(F)=C2N4CCN(C)CC4)=O

9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid

(-20℃)

With Ice Pack

≥ 2 years